Pharma [e] cology: how the gut microbiome contributes to variations in drug response

KR Trepka, CA Olson, V Upadhyay… - Annual Review of …, 2024 - annualreviews.org
Drugs represent our first, and sometimes last, line of defense for many diseases, yet despite
decades of research we still do not fully understand why a given drug works in one patient …

Non-SCFA microbial metabolites associated with fiber fermentation and host health

ET Grant, H De Franco, MS Desai - Trends in Endocrinology & Metabolism, 2024 - cell.com
Dietary fiber is degraded by commensal gut microbes to yield host-beneficial short-chain
fatty acids (SCFAs), but personalized responses to fiber supplementation highlight a role for …

[HTML][HTML] Microbiome-based therapeutics for Parkinson's disease

AM Hamilton, IN Krout, AC White, TR Sampson - Neurotherapeutics, 2024 - Elsevier
Recent experimental and clinical data demonstrate a significant dysregulation of the gut
microbiome in individuals with Parkinson's disease (PD). With an immense influence on all …

Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration

NU Mahbub, MM Islam, ST Hong… - Frontiers in Cellular and …, 2024 - frontiersin.org
Abnormal behavior of α-synuclein and prion proteins is the hallmark of Parkinson's disease
(PD) and prion illnesses, respectively, being complex neurological disorders. A primary …

Metagenomic Analysis Reveals Large‐Scale Disruptions of the Gut Microbiome in Parkinson's Disease

A Metcalfe‐Roach, MS Cirstea, AC Yu… - Movement …, 2024 - Wiley Online Library
Background Parkinson's disease (PD) has been consistently linked to alterations within the
gut microbiome. Objective Our goal was to identify microbial features associated with PD …

Advice to People with Parkinson's in My Clinic: Probiotics and Prebiotics

JW Hor, TS Toh, SY Lim… - Journal of Parkinson's …, 2024 - journals.sagepub.com
There is increasing evidence that microbial-based therapies can be useful in people with
Parkinson's disease (PD). In this viewpoint, we provide a state-of-the-art review of the …

[PDF][PDF] Gut-directed therapy in Parkinson's disease

L Benvenuti, C Di Salvo, G Bellini… - Frontiers in …, 2024 - researchgate.net
Parkinson's disease (PD) is a frequent, slow-progressing neurodegenerative disease that
affects over six million individuals worldwide with a growing economic impact on society …

Neurotoxicology of dopamine: victim or assailant?

ML Bucher, J Dicent, CD Hospital, GW Miller - NeuroToxicology, 2024 - Elsevier
Since the identification of dopamine as a neurotransmitter in the mid-20th century,
investigators have examined the regulation of dopamine homeostasis at a basic biological …

A prebiotic diet intervention can restore faecal short chain fatty acids in Parkinson's Disease yet fails to restore the gut microbiome homeostasis

JR Bedarf, S Romano, SS Heinzmann, A Duncan… - medRxiv, 2024 - medrxiv.org
Despite extensive research, current treatment of Parkinson's Disease (PD) remains
symptomatic and disease modifying approaches are urgently required. A promising …

Dietary L-3, 4-dihydroxyphenylalanine (L-DOPA) augments cuticular melanization in Anopheles mosquitos while reducing their lifespan and malaria parasite burden

E Camacho, Y Dong, C Chrissian, RJB Cordero… - bioRxiv, 2024 - biorxiv.org
L-3, 4-dihydroxyphenylalanine (L-DOPA), a naturally occurring tyrosine derivative, is
prevalent in environments that include mosquito habitats, potentially serving as part of their …